{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:55:58Z","timestamp":1790596558357,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.transci.2026.104520","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:26:15Z","timestamp":1787153175000},"page":"104520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and risk factors of red blood cell alloimmunization among sickle cell disease patients in resource-limited countries: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"65","author":[{"given":"Okeke","family":"Chinedu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Zilli","family":"Peroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique","family":"Gnoatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolfh Batista","family":"Arend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Marchi","family":"Kieling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natan Lucca","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Dreyer","family":"Brockstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9637-643X","authenticated-orcid":false,"given":"Israel Farias","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinwe","family":"Nwachukwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbuzu","family":"Perpetua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obiageli","family":"Nnodu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2026.104520_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/B978-0-12-802973-2.00018-5","article-title":"Sickle cell disease","volume":"138","author":"Strouse","year":"2016","journal-title":"Handb Clin Neurol"},{"issue":"9861","key":"10.1016\/j.transci.2026.104520_bib2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.transci.2026.104520_bib3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.hoc.2022.03.008","article-title":"Gene therapy for hemoglobinopathies","volume":"36","author":"Leonard","year":"2022","journal-title":"Beta-Thalass Sick Cell Dis Hematol Oncol Clin North Am"},{"issue":"8","key":"10.1016\/j.transci.2026.104520_bib4","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1111\/trf.15453","article-title":"Personalizing transfusion in sickle cell disease: where is the canary in the mine?","volume":"59","author":"Fields","year":"2019","journal-title":"Transfusion"},{"issue":"9757","key":"10.1016\/j.transci.2026.104520_bib5","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2026.104520_bib6","doi-asserted-by":"crossref","unstructured":"Helman R., Can\u00e7ado R.D., Olivatto C. Incidence of alloimunization in sickle cell disease: experience of a center in S\u00e3o Paulo. Einstein (Sao Paulo). 2011;9(2):160-4. English, Portuguese. doi: 10.1590\/S1679-45082011AO2003.","DOI":"10.1590\/s1679-45082011ao2003"},{"issue":"3","key":"10.1016\/j.transci.2026.104520_bib7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4314\/ahs.v24i3.46","article-title":"Frequency of red blood cell allo-immunization in transfused patients with sickle cell disease in Africa: a systematic review with meta-analysis","volume":"24","author":"Nwagha","year":"2024","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.transci.2026.104520_bib8","series-title":"Cochrane handbook for systematic reviews of interventions","year":"2019"},{"key":"10.1016\/j.transci.2026.104520_bib9","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.transci.2026.104520_bib10","unstructured":"Roser M., Rohenkohl B., Arriagada P., Hasell J., Ritchie H., Ortiz-Ospina E. World Bank income groups [Internet]. Our World in Data; 2025 [cited 2025 Dec 18]. Available from: https:\/\/archive.ourworldindata.org\/20251021-211801\/grapher\/world-bank-income-groups.html."},{"issue":"3","key":"10.1016\/j.transci.2026.104520_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jep.12884","article-title":"Improving the usefulness of a tool for appraising the quality of qualitative, quantitative and mixed methods studies, the Mixed Methods Appraisal Tool (MMAT)","volume":"24","author":"Hong","year":"2018","journal-title":"J Eval Clin Pract"},{"issue":"4","key":"10.1016\/j.transci.2026.104520_bib12","first-page":"61","article-title":"Red blood cell alloimmunization among sudanese homozygous sickle cell disease patients","volume":"3","author":"Abbas","year":"2013","journal-title":"Am J Med Med Sci"},{"issue":"10","key":"10.1016\/j.transci.2026.104520_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/BJMMR\/2016\/21755","article-title":"Erythrocyte transfusion and alloimmunisation patterns among sickle cell disease patients, Benin City, Nigeria","volume":"11","author":"Adewoyin","year":"2016","journal-title":"Br J Med Med Res"},{"issue":"3","key":"10.1016\/j.transci.2026.104520_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.21307\/immunohematology-2021-020","article-title":"Immune erythrocyte antibodies in adult patients with sickle cell disease and blood donors in Lagos, Nigeria: a comparative study","volume":"37","author":"Adewoyin","year":"2021","journal-title":"Immunohematology"},{"issue":"4","key":"10.1016\/j.transci.2026.104520_bib15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.tracli.2010.09.002","article-title":"Multiple transfusions for sickle cell disease in the Democratic Republic of Congo: the importance of the hepatitis C virus","volume":"17","author":"Agasa","year":"2010","journal-title":"Transfus Clin Biol"},{"issue":"11","key":"10.1016\/j.transci.2026.104520_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.36348\/sjpm.2022.v07i11.005","article-title":"Prevalence and specificities of immune red cell antibodies in adult patients with sickle cell anaemia and blood donors in Uyo, South-South Nigeria: a case-control study","volume":"7","author":"Akpan","year":"2022","journal-title":"Saudi J Pathol Microbiol"},{"issue":"3","key":"10.1016\/j.transci.2026.104520_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.transci.2012.07.014","article-title":"Frequency of red cell alloimmunization in patients with sickle cell anemia in an Egyptian referral hospital","volume":"47","author":"Aly","year":"2012","journal-title":"Transfus Apher Sci"},{"issue":"6","key":"10.1016\/j.transci.2026.104520_bib18","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/trf.15197","article-title":"Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease","volume":"59","author":"Boateng","year":"2019","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.transci.2026.104520_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2025.104107","article-title":"The prevalence and pattern of alloimmunization in patients with sickle cell disease in Abuja, Nigeria","volume":"64","author":"Chinedu","year":"2025","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2026.104520_bib20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.tracli.2013.04.111","article-title":"S\u00e9curit\u00e9 transfusionnelle et dr\u00e9panocytose \u00e0 Bamako, Mali. S\u00e9ropr\u00e9valence des infections \u00e0 VIH, VHB, VHC et allo-immunisation anti-Rh et Kell chezles dr\u00e9panocytaires","volume":"20","author":"Diarra","year":"2013","journal-title":"Transfus Clin Et Biol"},{"issue":"12","key":"10.1016\/j.transci.2026.104520_bib21","first-page":"137","article-title":"Red cell alloimmunization in blood transfusion dependent Patients with Sickle Cell Disease in El-Obied city, Sudan","volume":"14","author":"Eldour","year":"2015","journal-title":"IOSR-JDMS"},{"issue":"1","key":"10.1016\/j.transci.2026.104520_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.21608\/jbaar.2020.115765","article-title":"RBC alloimmunization in Sudanese multi-transfused patients","volume":"6","author":"Elkobani","year":"2020","journal-title":"J Biosci Appl Res"},{"key":"10.1016\/j.transci.2026.104520_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3518402","article-title":"Efficacy and safety of manual partial red cell exchange in the management of severe complications of sickle cell disease in a developing country","volume":"2017","author":"Faye","year":"2017","journal-title":"Adv Hematol"},{"issue":"5","key":"10.1016\/j.transci.2026.104520_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/tme.13074","article-title":"Prevalence of red blood cell alloantibodies in pregnant women with sickle cell disease in Bamako","volume":"34","author":"Fomba","year":"2024","journal-title":"Transfus Med"},{"issue":"1","key":"10.1016\/j.transci.2026.104520_bib25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/ijmr.IJMR_940_17","article-title":"Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion","volume":"149","author":"Jariwala","year":"2019","journal-title":"Indian J Med Res"},{"issue":"2","key":"10.1016\/j.transci.2026.104520_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/tme.12939","article-title":"Red blood cell alloimmunisation in sickle cell disease patients in the Democratic Republic of the Congo","volume":"33","author":"Kambale-Kombi","year":"2023","journal-title":"Transfus Med"},{"key":"10.1016\/j.transci.2026.104520_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40364-015-0050-3","article-title":"Pattern and prevalence of alloimmunization in multiply transfused patients with sickle cell disease in Nigeria","volume":"3","author":"Kangiwa","year":"2015","journal-title":"Biomark Res"},{"issue":"9","key":"10.1016\/j.transci.2026.104520_bib28","article-title":"Assessing alloimmunization in sickle cell disease patients: insights from a tertiary care center study on multiple blood transfusion recipients in central India","volume":"17","author":"Kshatriya","year":"2025","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.transci.2026.104520_bib29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4102\/ajlm.v4i1.297","article-title":"Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi, Kenya","volume":"4","author":"Mangare","year":"2015","journal-title":"Afr J Lab Med"},{"issue":"2","key":"10.1016\/j.transci.2026.104520_bib30","first-page":"775","article-title":"Red blood cell alloimmunization in sickle cell disease patients in Tanzania","volume":"11","author":"Meda","year":"2014","journal-title":"East Afr J Public Health"},{"issue":"1","key":"10.1016\/j.transci.2026.104520_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1537-2995.2009.02435.x","article-title":"Red blood cell alloimmunization in sickle cell disease patients in Uganda","volume":"50","author":"Natukunda","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2026.104520_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5356245","article-title":"Frequency of red blood cell alloimmunization in patients with sickle cell disease in Palestine","volume":"2018","author":"Samarah","year":"2018","journal-title":"Adv Hematol"},{"issue":"1","key":"10.1016\/j.transci.2026.104520_bib33","first-page":"1","article-title":"Anti-erythrocyte allo-immunization to sickle cell disease patients followed in transfusion therapy unit of the national blood transfusion center of Abidjan C\u00f4te D\u2019Ivoire","volume":"5","author":"Sekongo","year":"2017","journal-title":"Sci Publ Group"},{"key":"10.1016\/j.transci.2026.104520_bib34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.phoj.2023.05.004","article-title":"Alloimmunization in children with sickle cell disease: a tertiary care experience","volume":"8","author":"Sharma","year":"2023","journal-title":"Pediatr Hematol Oncoloy J"},{"issue":"1","key":"10.1016\/j.transci.2026.104520_bib35","first-page":"1","article-title":"Immune status and red cell alloimmunization among SCD patients in C\u00f4te d\u2019Ivoire","volume":"3","author":"Siransy","year":"2018","journal-title":"J Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.transci.2026.104520_bib36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4102\/ajlm.v9i1.823","article-title":"Prevalence and risk factors for red blood cell alloimmunisation among sickle cell patients in Mwanza City, Tanzania","volume":"9","author":"Tebuka","year":"2020","journal-title":"Afr J Lab Med"},{"issue":"4","key":"10.1016\/j.transci.2026.104520_bib37","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4103\/1119-3077.154204","article-title":"Red cell alloimmunization in multi-transfused patients with sickle cell anemia in Benin City, Nigeria","volume":"18","author":"Ugwu","year":"2015","journal-title":"Niger J Clin Pract"},{"issue":"4","key":"10.1016\/j.transci.2026.104520_bib38","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s12288-023-01651-4","article-title":"Study of the frequency and specificity of red cell antibodies in patients with hemoglobinopathies","volume":"39","author":"Wilson","year":"2023","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"3","key":"10.1016\/j.transci.2026.104520_bib39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tmrv.2019.06.003","article-title":"Red blood cell alloimmunization in transfused patients with sickle cell disease in sub-saharan africa; a systematic review and meta-analysis","volume":"33","author":"Boateng","year":"2019","journal-title":"Transfus Med Rev"},{"issue":"2","key":"10.1016\/j.transci.2026.104520_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5348\/100080Z02AH2023RA","article-title":"Evaluation of the prevalence of anti\u2011erythrocyte alloimmunization in 100 polytransfused patients in Lom\u00e9, Togo","volume":"13","author":"Hounogb\u00e9","year":"2023","journal-title":"Int J Blood Transfus Immunohematol"},{"key":"10.1016\/j.transci.2026.104520_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.21307\/immunohematology-2018-011","article-title":"Rh and Kell blood group antigen prevalence in a multi\u2011ethnic cohort in Nigeria: implications for local transfusion service","volume":"34","author":"Adewoyin","year":"2018","journal-title":"Immunohematology"},{"issue":"3","key":"10.1016\/j.transci.2026.104520_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/tme.12314","article-title":"Alloimmunisation rates of sickle cell disease patients in the United States differ from those in other geographical regions","volume":"26","author":"Zheng","year":"2016","journal-title":"Transfus Med"},{"issue":"3","key":"10.1016\/j.transci.2026.104520_bib43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.12691\/ajcmr-1-3-2","article-title":"Delayed hemolytic transfusion reaction in sickle cell disease","volume":"1","author":"Elenga","year":"2013","journal-title":"Am J Clin Med Res"},{"issue":"3","key":"10.1016\/j.transci.2026.104520_bib44","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.hoc.2016.01.011","article-title":"Management of patients with sickle cell disease using transfusion therapy","volume":"30","author":"Chou","year":"2016","journal-title":"Guidel Complicat Hematol Oncol Clin North Am"},{"issue":"11","key":"10.1016\/j.transci.2026.104520_bib45","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.17219\/acem\/140317","article-title":"High-sensitivity detection of clinically significant red blood cell antibodies by the column agglutination technique","volume":"30","author":"Charong","year":"2021","journal-title":"Adv Clin Exp Med"},{"issue":"4","key":"10.1016\/j.transci.2026.104520_bib46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tmrv.2016.05.011","article-title":"Red blood cell antigen genotyping for sickle cell disease, thalassemia, and other transfusion complications","volume":"30","author":"Fasano","year":"2016","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.transci.2026.104520_bib47","series-title":"The blood group antigen factsbook","first-page":"32","author":"Reid","year":"2012"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226001527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226001527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:04:56Z","timestamp":1790593496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050226001527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1473050226001527"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2026.104520","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and risk factors of red blood cell alloimmunization among sickle cell disease patients in resource-limited countries: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2026.104520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104520"}}